Position in ZTS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,762,222
-$235,763 QoQ
Shares Held
24,523
+45.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#507
of 1,408 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL SECURITIES, INC. holds $4,721,012 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
24,523 | $1,762,222 | |
| 2 | HLN |
Haleon plc
|
148,878 | $1,389,031 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
910 | $493,065 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,887 | $486,574 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,678 | $427,176 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
10,165 | $162,944 |
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,762,222 | 24,523 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,997,985 | 16,902 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,185,979 | 9,426 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,519,972 | 10,388 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,759,271 | 11,281 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,841,280 | 11,183 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,822,046 | 11,183 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,425,251 | 12,413 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,878,702 | 10,837 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,580,252 | 9,339 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,625,341 | 8,235 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||